Evidence map›Paper›PMID 30294923›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2018

Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells.

Amy M Smith, Constanze Depp, Brent J Ryan, Geoffrey I Johnston, Javier Alegre-Abarrategui, Samuel Evetts, Michal Rolinski, Fahd Baig, Claudio Ruffmann, Anna Katharina Simon and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 120 citations in OpenAlex.

  1. Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Aberrant CD4bioRxiv : the preprint server for biology · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Peripheral Mononuclear Cell Mitochondrial Function Associates with T-Cell Cytokines in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Amy M SmithOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
Constanze DeppOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
Brent J RyanOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
Geoffrey I JohnstonGlobal Exploratory Development, New Medicines, UCB Pharma, Slough, UK.
Javier Alegre-AbarrateguiOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
Samuel EvettsOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
Michal RolinskiOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
Fahd BaigOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
Claudio RuffmannOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
Anna Katharina SimonTranslational Immunology Laboratory, NIHR BRC, University of Oxford, Oxford, UK.
Michele T M HuOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
Richard Wade-MartinsOxford Parkinson's Disease Centre, University of Oxford, Oxford, UK.
University of Oxford · GBUCB Pharma (United Kingdom) · GB

Funding

Medical Research Council MR/L023784/1NIHR Biomedical Research CentreParkinson's UK J-0901UCB PharmaWellcome Trust
6 · The paper itself

Abstract

backgroundAlthough primarily a neurodegenerative process, there is increasing awareness of peripheral disease mechanisms in Parkinson's disease. To investigate disease processes in accessible patient cells, we studied peripheral blood mononuclear cells in recently diagnosed PD patients and rapid eye movement-sleep behavior disorder patients who have a greatly increased risk of developing PD. We hypothesized that peripheral blood mononuclear cells may recapitulate cellular pathology found in the PD brain and investigated these cells for mitochondrial dysfunction and oxidative stress.

methodsPeripheral blood mononuclear cells were isolated and studied from PD patients, rapid eye movement-sleep behavior disorder patients and age- and sex-matched control individuals from the well-characterized Oxford Discovery cohort. All participants underwent thorough clinical assessment.

resultsInitial characterization showed that PD patients had elevated levels of CD14 + monocytes and monocytes expressing C-C motif chemokine receptor 2. Mitochondrial dysfunction and oxidative stress were increased in PD patient peripheral blood mononuclear cells, with elevated levels of mitochondrial reactive oxygen species specifically in patient monocytes. This was combined with reduced levels of the antioxidant superoxide dismutase in blood cells from PD patients and, importantly, also in rapid eye movement-sleep behavior disorder patients. This mitochondrial dysfunction was associated with a concomitant increase in glycolysis in both PD and rapid eye movement-sleep behavior disorder patient blood cells independent of glucose uptake or monocyte activation.

conclusionsThis work demonstrates functional bioenergetic deficits in PD and rapid eye movement-sleep behavior disorder patient blood cells during the early stages of human disease. © 2018 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Indexed as

Case-Control StudiesCytokinesElectron Transport Complex IVEnzyme InhibitorsFemaleFlow CytometryGene Expression RegulationGlucoseGlucose Transporter Type 1GlycolysisHumansLeukocytes, MononuclearMaleMitochondriaMitochondrial DiseasesOxygen ConsumptionCCR2 protein, humanCytokinesElectron Transport Complex IVEnzyme InhibitorsGlucoseGlucose Transporter Type 1Reactive Oxygen SpeciesReceptors, CCR2RNA, MessengerSLC2A1 protein, humanSuperoxide Dismutaseglycolysismitochondrial dysfunctionParkinson's diseaseperipheral blood mononuclear cellsREM-sleep behavior disorder

Identifiers

PMID30294923
PMCPMC6221131
OpenAlexW2897936802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.